Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
0.9150
-0.0649 (-6.62%)
At close: Apr 1, 2025, 4:00 PM
0.9229
+0.0078 (0.86%)
After-hours: Apr 1, 2025, 7:07 PM EDT

Pyxis Oncology Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-77.33-73.79-120.72-75.98-12.83
Upgrade
Depreciation & Amortization
2.981.930.710.650.47
Upgrade
Asset Writedown & Restructuring Costs
20.96-9.2820-
Upgrade
Loss (Gain) From Sale of Investments
-6.11-4.79---
Upgrade
Loss (Gain) on Equity Investments
---0.05-
Upgrade
Stock-Based Compensation
12.9516.9515.766.440.04
Upgrade
Other Operating Activities
0.610.661.136.840.37
Upgrade
Change in Accounts Payable
1.2-3.51-8.334.640.56
Upgrade
Change in Unearned Revenue
-7.661---
Upgrade
Change in Other Net Operating Assets
-3.1-9.1612.832.031.31
Upgrade
Operating Cash Flow
-57.67-70.71-89.34-35.33-10.08
Upgrade
Capital Expenditures
-0.24-6.73-6.4-0.54-1.48
Upgrade
Cash Acquisitions
-6.66---
Upgrade
Investment in Securities
8.39-104.78--0.05-
Upgrade
Investing Cash Flow
8.16-104.85-6.4-0.59-1.48
Upgrade
Issuance of Common Stock
59.576.370.18152.460.04
Upgrade
Repurchase of Common Stock
-0.24-0.45---
Upgrade
Financing Cash Flow
59.335.930.18304.040.04
Upgrade
Net Cash Flow
9.81-169.63-95.55268.13-11.53
Upgrade
Free Cash Flow
-57.91-77.44-95.73-35.87-11.57
Upgrade
Free Cash Flow Margin
-358.66%----
Upgrade
Free Cash Flow Per Share
-0.99-1.94-2.90-4.22-11.22
Upgrade
Cash Interest Paid
0.010---
Upgrade
Cash Income Tax Paid
0.160.050.02--
Upgrade
Levered Free Cash Flow
-33.79-43.21-57.39-25.47-6.69
Upgrade
Unlevered Free Cash Flow
-33.79-43.21-57.39-25.47-6.69
Upgrade
Change in Net Working Capital
8.55.09-9.71-11.55-2.34
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q